PFE  Pfizer Inc.

Exchange

NYSE

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

197.0B

Vuru Grade

56.97/100

Current Price

$30.86
+0.61 (+2.02%)

Growth Price

$28.24
Overvalued by 8.47%

Stability Price

$7.93
Overvalued by 74.30%

Company Metrics

  • 9.48 P/E
  • 3.74 P/S
  • 2.54 P/B
  • 3.191 EPS
  • 15.13% Cash ROIC
  • 0.95 Cash Ratio
  • 0.98 / 3.24% Dividend
  • 28.90M Avg. Vol.
  • 7.87B Shares
  • 197.0B Market Cap.

Company Description

Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. The company's Biopharmaceutical segment's provides Lipitor for elevated LDL-cholesterol levels in the blood; Enbrel for rheumatoid arthritis, polyarticular juvenile rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis; Lyrica for post-herpetic neuralgia, diab...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

There is no news available at this time.